Amgen, NHS strike deal to expand Lumykras access in UK as watchdog weighs its merits
Summary : While England’s drug-price watchdog continues to assess the value of Amgen’s lung cancer drug Lumykras, the company and the National…
Summary : While England’s drug-price watchdog continues to assess the value of Amgen’s lung cancer drug Lumykras, the company and the National…